Lexicon Pharmaceuticals, Inc. (LXRX): who owns it and who trades it
As of Nov 16, 2026, LXRX insiders reported 9 purchases worth $2.8M in the last 12 months. The largest buyer was Artal Group S.A. (Director), with $2M. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Lexicon Pharmaceuticals
From the latest filingsOverall: about as much buying as selling. Famous investors mostly sold. Insiders mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns LXRX
148 funds and institutions reported LXRX shares worth $880M at the end of Q2 2026, about 87% of the company. The largest holder is Artal Group S.A. with 41.3%.
Funds and institutions (13F) 87%Everyone else 13%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Artal Group S.A. | 175.16M | 41.34% | $420M | +13% |
| FMR LLC (Fidelity) | 51.78M | 12.22% | $124M | +15% |
| Siren, L.L.C. | 44.30M | 10.46% | $106M | No change |
| Sessa Capital IM, L.P. | 18.96M | 4.48% | $45.5M | +6% |
| BlackRock, Inc. | 17.35M | 4.09% | $41.6M | +422% |
| Vanguard Capital Management LLC | 9.90M | 2.34% | $23.8M | +4% |
| Point72 Asset Management, L.P. | 8.25M | 1.95% | $19.8M | +6% |
| Geode Capital Management, LLC | 6.24M | 1.47% | $15M | +97% |
| State Street Corp | 4.92M | 1.16% | $11.8M | +410% |
| Vanguard Portfolio Management LLC | 2.36M | 0.56% | $5.7M | +331% |
| Northern Trust Corp | 1.97M | 0.46% | $4.7M | +298% |
| Charles Schwab Investment Management Inc | 1.96M | 0.46% | $4.7M | +49% |
| Sixth Street Partners Management Company, L.P. | 1.96M | 0.46% | $4.7M | – |
| Vanguard Fiduciary Trust Co | 1.63M | 0.39% | $3.9M | +23% |
| Citadel Advisors LLC | 1.60M | 0.38% | $3.8M | +46% |
| Ishara Investments LP | 1.27M | 0.30% | $3.1M | +41% |
| Millennium Management LLC | 1.13M | 0.27% | $2.7M | -77% |
| Renaissance Technologies LLC | 1.13M | 0.27% | $2.7M | -30% |
| Mackenzie Financial Corp | 963,354 | 0.23% | $2.3M | +25% |
| ADAR1 Capital Management, LLC | 750,000 | 0.18% | $1.8M | No change |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, LXRX insiders reported $2.8M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Michael Exton | CEO | Purchase | 30,064 | $1.66 | $50K | Form 4 |
| Feb 25, 2026 | Raymond Debbane | Director | Purchase | 2,000 | $1.49 | $3K | Form 4 |
| Feb 23, 2026 | Raymond Debbane | Director | Purchase | 100,000 | $1.47 | $147K | Form 4 |
| Feb 20, 2026 | Raymond Debbane | Director | Purchase | 100,000 | $1.48 | $148K | Form 4 |
| Feb 19, 2026 | Raymond Debbane | Director | Purchase | 50,000 | $1.44 | $72K | Form 4 |
| Feb 18, 2026 | Raymond Debbane | Director | Purchase | 133,688 | $1.32 | $176K | Form 4 |
| Feb 17, 2026 | Raymond Debbane | Director | Purchase | 76,857 | $1.31 | $101K | Form 4 |
| Feb 13, 2026 | Raymond Debbane | Director | Purchase | 57,952 | $1.31 | $75.9K | Form 4 |
| Feb 2, 2026 | Artal Group S.A. +8 | Director | Purchase | 1.54M | $1.30 | $2M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Artal Group S.A. | Director, 10% owner | $2M | – | Feb 2, 2026 |
| Raymond Debbane | Director | $723K | – | Feb 25, 2026 |
| Michael Exton | Chief Executive Officer, Director | $50K | – | Nov 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
LXRX short interest
Moderate short interest. 5.8% of LXRX shares are sold short: about 1 share in 17. Over the last 12 reports the number of shares short went down 1%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 25.88M LXRX shares were sold short, 5.8% of the shares outstanding, down 3.1% from the report before. At the average daily volume of 1.84M shares, buying them all back would take about 14.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 25.88M | 5.82% | -3% | 1.84M | 14.0 |
| Oct 15, 2026 | 26.70M | 6.00% | +3% | 2.06M | 13.0 |
| Sep 30, 2026 | 25.83M | 5.80% | -10% | 4.19M | 6.2 |
| Sep 15, 2026 | 28.79M | 6.47% | -2% | 2.15M | 13.4 |
| Aug 31, 2026 | 29.49M | 6.63% | -10% | 2.87M | 10.3 |
| Aug 14, 2026 | 32.75M | 7.36% | -0% | 3.00M | 10.9 |
| Jul 31, 2026 | 32.83M | 7.75% | +0% | 2.63M | 12.5 |
| Jul 15, 2026 | 32.73M | 7.73% | +6% | 2.72M | 12.0 |
| Jun 30, 2026 | 30.78M | 7.27% | +21% | 6.93M | 4.4 |
| Jun 15, 2026 | 25.43M | 6.00% | -3% | 2.02M | 12.6 |
| May 29, 2026 | 26.21M | 6.19% | +0% | 1.91M | 13.7 |
| May 15, 2026 | 26.14M | 6.17% | +10% | 4.20M | 6.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Lexicon Pharmaceuticals company events
Lexicon Pharmaceuticals filed 8 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- May 7, 2026ResultsReleased financial results. Filing
- May 6, 2026AgreementLexicon Pharmaceuticals, Inc. and its subsidiaries entered into a loan and security agreement with Hercules Capital, Inc. and certain of its affiliates that provides up to $100 million in borrowing capacity available in three tranches, each maturing in May 2030. Filing
- Apr 30, 2026AgreementSigned an important agreement. Filing
- Mar 5, 2026ResultsReleased financial results. Filing
- Feb 2, 2026AgreementLexicon Pharmaceuticals, Inc. entered into an Underwriting Agreement with Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein, relating to a public offering of 32,000,000 shares of the Company’s common stock, par value $0.001 per share. Filing
- Jan 29, 2026AnnouncementThe information set forth in Item 2.02 of this Current Report is hereby incorporated in this Item 8.01 by reference. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Lexicon Pharmaceuticals financials
Famous investors that hold LXRX
3 of the 50 well-known investors we track reported holding LXRX in their latest 13F filing. The largest position is Ken Griffin's, worth $2.7M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.46M | $2.7M | 0.0% | -9% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 988,279 | $1.9M | 0.0% | -88% |
| Israel Englander · Millennium Management | Q3 2026 | 786,034 | $1.5M | 0.0% | -31% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named LXRX in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 5, 2026 | FMR LLC | 13G/A | 15.0% |
| Nov 5, 2026 | FMR LLC | 13G/A | 15.0% |
Questions about Lexicon Pharmaceuticals, Inc. (LXRX) stock
Who owns the most LXRX stock?
The largest reported owner of Lexicon Pharmaceuticals, Inc. (LXRX) is Artal Group S.A., with 41.3% of the company. In total, 148 funds and institutions reported holding LXRX at the end of Q2 2026, together about 87% of the shares. See the largest owners.
Are LXRX insiders buying or selling?
In the last 12 months, LXRX insiders reported 9 open-market purchases worth $2.8M and no sales. The latest trade was on Nov 6, 2026. See every trade.
What is the short interest in LXRX?
As of Oct 30, 2026, 25.88M LXRX shares were sold short, 5.8% of the shares outstanding, down 3.1% from the report before. At the average daily volume of 1.84M shares, buying them all back would take about 14.0 trading days (days to cover). See the history.
Which famous investors hold LXRX?
3 of the 50 well-known investors we track reported LXRX in their latest 13F filing, including Ken Griffin, Steve Cohen, Israel Englander. The largest position is worth $2.7M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.